The emerging therapy of this peptide represents a significant breakthrough in the management of the condition. Distinct from existing therapies, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide106468.prublogger.com/40827408/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment